Literature DB >> 2969889

Modulation of interleukin-1 receptor expression and interleukin-1 response in fibroblasts by platelet-derived growth factor.

P D Bonin1, J P Singh.   

Abstract

Our studies have revealed that the interleukin-1 (IL-1) receptors and response in BALB/c/3T3 fibroblasts are modulated by platelet-derived growth factor (PDGF). Incubation of quiescent cultures of BALB/c/3T3 fibroblasts with PDGF resulted in 4-5 fold higher 125I-IL-1 binding than the untreated cultures. Scatchard analysis showed that the increased 125I-IL-1 binding by PDGF-treated cells was due to a net increase in cell surface IL-1 receptors with no apparent change in binding affinity. The PDGF-induced increase of 125I-IL-1 binding was blocked by inhibitors of transcription, suggesting that a transcriptional event, perhaps a de novo synthesis of IL-1 receptors, is required for PDGF response. In a culture medium depleted of serum factors, IL-1 alone produced only a marginal (40-50%) increase in DNA synthesis in BALB/c/3T3 cells. In cells first exposed to PDGF, IL-1 produced 8-10-fold higher DNA synthesis than the controls. These findings provide evidence that IL-1 action in fibroblast may be regulated at the level of receptor expression.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969889

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Modulation of muscarinic-receptor expression in human embryonic lung fibroblasts by platelet-derived growth factor.

Authors:  A Koman; O Durieu-Trautmann; P O Couraud; A D Strosberg; B B Weksler
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

3.  Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action.

Authors:  C M Dubois; F W Ruscetti; E W Palaszynski; L A Falk; J J Oppenheim; J R Keller
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

4.  Ca2+ responses to interleukin 1 and tumor necrosis factor in cultured human skin fibroblasts. Possible implications for Reye syndrome.

Authors:  B E Corkey; J F Geschwind; J T Deeney; D E Hale; S D Douglas; L Kilpatrick
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

5.  Modulatory role of platelet-derived growth factor on cytokine-induced nerve growth factor synthesis in rat glomerular mesangial cells.

Authors:  K M Plüss; J Pfeilschifter; H Mühl; A Huwiler; C Boeckh; U Otten
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

6.  Interleukin-1 beta regulation of fibroblast proteoglycan synthesis involves a decrease in versican steady-state mRNA levels.

Authors:  E E Qwarnström; H T Järveläinen; M G Kinsella; C O Ostberg; L J Sandell; R C Page; T N Wight
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

7.  Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm.

Authors:  Shivam Rai; Elodie Grockowiak; Nils Hansen; Damien Luque Paz; Cedric B Stoll; Hui Hao-Shen; Gabriele Mild-Schneider; Stefan Dirnhofer; Christopher J Farady; Simón Méndez-Ferrer; Radek C Skoda
Journal:  Nat Commun       Date:  2022-09-13       Impact factor: 17.694

8.  Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor.

Authors:  T Hoang; B Levy; N Onetto; A Haman; J C Rodriguez-Cimadevilla
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.